Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Non-cash Items (2020 - 2025)

TELA Bio has reported Non-cash Items over the past 6 years, most recently at $1.7 million for Q4 2025.

  • Quarterly results put Non-cash Items at $1.7 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $1.7 million (changed N/A YoY), and the annual figure for FY2025 was $1.7 million, changed.
  • Non-cash Items for Q4 2025 was $1.7 million at TELA Bio, roughly flat from $1.7 million in the prior quarter.
  • Over the last five years, Non-cash Items for TELA hit a ceiling of $7.4 million in Q2 2021 and a floor of $200000.0 in Q2 2025.
  • Median Non-cash Items over the past 5 years was $1.6 million (2024), compared with a mean of $1.9 million.
  • Biggest five-year swings in Non-cash Items: surged 1678.1% in 2021 and later plummeted 93.24% in 2022.
  • TELA Bio's Non-cash Items stood at $3.0 million in 2021, then changed by 0.0% to $3.0 million in 2022, then plummeted by 90.0% to $300000.0 in 2023, then surged by 437.43% to $1.6 million in 2024, then rose by 6.3% to $1.7 million in 2025.
  • The last three reported values for Non-cash Items were $1.7 million (Q4 2025), $1.7 million (Q3 2025), and $200000.0 (Q2 2025) per Business Quant data.